ASSA ABLOY AB ser. B (0R87)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 380.35 |
|---|---|
| 52-week range | 314.50 – 396.80 |
| Return, 1 month / 3 months | +7.1% / +8.3% |
| Return, 1 year / 3 years | +6.7% / +74.4% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 21.1% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 138.96M SEK |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ASSA ABLOY AB is a Swedish manufacturer of locks, door hardware and access control systems. The company supplies mechanical and electronic locks, door closers, hinges, and entrance automation equipment, along with security and identification products. Its customers include building owners, contractors, architects and institutions such as hospitals, schools and offices, and it operates across Europe, the Americas, Asia and other regions. The group is headquartered in Stockholm, Sweden, and its products are used in residential, commercial and public buildings.
On this site ASSA ABLOY AB ser. B appears as a stock on the London Stock Exchange (UK), code 0R87, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ASSA ABLOY AB ser. B (0R87) trades on the London Stock Exchange in UK. It last closed at SEK 380.35 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 486 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.7% and over the last three months it rose 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.1% | ||
| From 52-week high | -3.9% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.3% | ||
| 6-month return | 4.2% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 138.96M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +7.5% |
|---|---|
| 1 month | +7.1% |
| 3 months | +8.3% |
| 6 months | +4.1% |
| 1 year | +6.7% |
| 3 years | +74.4% |
| 5 years | +70.2% |
Signals
| 50-day / 200-day average | 352.71 / 351.93 |
|---|---|
| Golden / death cross (60 days) | Golden, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | SEK 3.2000 |
| 10 Nov 2025 | SEK 2.9500 |
| 24 Apr 2025 | SEK 2.9500 |
| 8 Nov 2024 | SEK 2.7000 |
| 25 Apr 2024 | SEK 2.7000 |
| 10 Nov 2023 | SEK 2.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.